{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:29:10Z","timestamp":1784687350649,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.euroneuro.2007.04.005","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T11:11:25Z","timestamp":1181646685000},"page":"24-33","source":"Crossref","is-referenced-by-count":32,"title":["The influence of clozapine treatment and other antipsychotics on the 18\u00a0kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production"],"prefix":"10.1016","volume":"18","author":[{"given":"Lena","family":"Danovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Veenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Leschiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Lahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Gavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2007.04.005_bib1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1471-4159.1987.tb01007.x","article-title":"Binding of [3H]Ro 5-4864 and [3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites","volume":"49","author":"Awad","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3181\/00379727-206-43752","article-title":"Prolactin and testicular Leydig cell function: characterization of prolactin receptors in the murine MA-10 testicular Leydig cell line","volume":"206","author":"Barkey","year":"1994","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0039-128X(74)90130-5","article-title":"Antiserum to 5alpha-dihydrotestosterone: production, characterization and use in radioimmunoassay","volume":"24","author":"Bauminger","year":"1974","journal-title":"Steroids"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2007.04.005_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002130000471","article-title":"Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat","volume":"15","author":"Bitran","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1210\/en.135.4.1576","article-title":"Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis","volume":"135","author":"Boujrad","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib8","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/en.141.9.3137","article-title":"The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells","volume":"141","author":"Boujrad","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/ajp.151.1.20","article-title":"Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia","volume":"151","author":"Breier","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0006-2952(99)00093-3","article-title":"Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line","volume":"58","author":"Carmel","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib12","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1021\/bi0267487","article-title":"In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding","volume":"42","author":"Delavoie","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib13","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229909000336","article-title":"Choices in antipsychotic therapy in schizophrenia","volume":"6","author":"Frankenburg","year":"1999","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(86)90500-5","article-title":"Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics","volume":"121","author":"Gavish","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0031-6997(24)01424-8","article-title":"Enigma of the peripheral benzodiazepine receptor","volume":"51","author":"Gavish","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib17","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1021\/bi010431+","article-title":"Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction","volume":"40","author":"Golani","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/appi.ajp.157.6.982","article-title":"Clozapine in the treatment of refractory psychotic mania","volume":"157","author":"Green","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-003-1761-y","article-title":"The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications","volume":"174","author":"Harrison","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 12","key":"10.1016\/j.euroneuro.2007.04.005_bib21","first-page":"22","article-title":"A historical perspective of clozapine","volume":"60","author":"Hippius","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib22","first-page":"62","article-title":"Clozapine in treatment-resistant schizophrenics","volume":"24","author":"Kane","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics?: a new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib25","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1074\/jbc.273.10.5478","article-title":"Effects of peripheral-type benzodiazepine receptor antisense knockout on MA-10 Leydig cell proliferation and steroidogenesis","volume":"273","author":"Kelly-Hershkovitz","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00172773","article-title":"Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine","volume":"352","author":"Korpi","year":"1995","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/BF01294737","article-title":"Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics","volume":"104","author":"Kurumaji","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0039-128X(03)00101-6","article-title":"Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis","volume":"68","author":"Lacapere","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib29","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1021\/bi050150s","article-title":"The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line","volume":"44","author":"Levin","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib32","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1073\/pnas.89.8.3170","article-title":"Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier","volume":"89","author":"McEnery","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1043-2760(01)00503-3","article-title":"Neurosteroids: biochemistry and clinical significance","volume":"13","author":"Mellon","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1749-6632.2001.tb05797.x","article-title":"Treatment of suicidality in schizophrenia","volume":"932","author":"Meltzer","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00008877-199404000-00011","article-title":"Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule","volume":"5","author":"Moore","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0924-9338(03)00060-9","article-title":"Antipsychotic treatment in schizophrenia: atypical options and NICE guidance","volume":"18","author":"Mortimer","year":"2003","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib37","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/S0021-9258(19)39661-9","article-title":"The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis","volume":"265","author":"Papadopoulos","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib38","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0303-7207(94)90061-2","article-title":"Topography of the Leydig cell mitochondrial peripheral-type benzodiazepine receptor","volume":"104","author":"Papadopoulos","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18\u00a0kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0306-4522(94)90330-1","article-title":"The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus","volume":"62","author":"Patchev","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0893-133X(96)00096-6","article-title":"The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus","volume":"15","author":"Patchev","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(95)90469-7","article-title":"Prospects for pharmacotherapy of schizophrenia","volume":"345","author":"Pickar","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-3223(95)00305-3","article-title":"Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression","volume":"40]","author":"Ranjan","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives","volume":"22","author":"Rupprecht","year":"1999","journal-title":"Trends Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2007.04.005_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-2406.2003.00062.x","article-title":"Atypical antipsychotics and suicide in mood and anxiety disorders","volume":"5","author":"Sharma","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-200022030-00004","article-title":"Tolerability of atypical antipsychotics","volume":"22","author":"Stanniland","year":"2000","journal-title":"Drug Safety"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"156","author":"Suppes","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib48","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<355::AID-DDR18>3.0.CO;2-W","article-title":"Peripheral-type benzodiazepine receptors: their implication in brain disease","volume":"50","author":"Veenman","year":"2000","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pharmthera.2005.09.007","article-title":"The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development","volume":"110","author":"Veenman","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.0022-3042.2002.00769.x","article-title":"PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain","volume":"80","author":"Veenman","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2004.05.011","article-title":"Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines","volume":"68","author":"Veenman","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00023210-200317040-00004","article-title":"Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder","volume":"17","author":"Wagstaff","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib54","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1021\/bi030251v","article-title":"Peripheral benzodiazepine receptor antisense knockout increases tumorigenicity of MA-10 Leydig cells in vivo and in vitro","volume":"43","author":"Weisinger","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.euroneuro.2007.04.005_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0024-3205(86)90512-6","article-title":"Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia","volume":"39","author":"Weizman","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(93)90393-V","article-title":"Modulatory effect of antidepressants on peripheral-type benzodiazepine receptors","volume":"250","author":"Weizman","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2007.04.005_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ajhp\/57.3.238","article-title":"Atypical antipsychotic agents: a critical review","volume":"57","author":"Worrel","year":"2000","journal-title":"Am. J. Health-Syst. Pharm."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0700096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X0700096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T06:24:32Z","timestamp":1737095072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X0700096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0924977X0700096X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.04.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}